These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12230217)

  • 21. Epidemiology, risk factors and antimicrobial profile of Vulvovaginal Candidiasis (VVC): A study among women in the central region of Saudi Arabia.
    Venugopal D; Husain K; Mustafa SA; Sabeen S
    J Mycol Med; 2021 Jun; 31(2):101049. PubMed ID: 33153879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The epidemiology of Candida species associated with vulvovaginal candidiasis in an Iranian patient population.
    Mahmoudi Rad M; Zafarghandi S; Abbasabadi B; Tavallaee M
    Eur J Obstet Gynecol Reprod Biol; 2011 Apr; 155(2):199-203. PubMed ID: 21194828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Frequency and antifungal profile of Candida isolated from vaginal exudates of preadolescent girls].
    Giusiano G; Rojas F; Toma-Vanacore S; Mangiaterra M
    Enferm Infecc Microbiol Clin; 2009; 27(7):428. PubMed ID: 19403204
    [No Abstract]   [Full Text] [Related]  

  • 24. Frequency of vagınal candida colonization and relationship between metabolic parameters in children with type 1 diabetes mellitus.
    Atabek ME; Akyürek N; Eklioglu BS
    J Pediatr Adolesc Gynecol; 2013 Oct; 26(5):257-60. PubMed ID: 24012126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Species spectrum and antifungal susceptibility profile of vaginal isolates of Candida in Kuwait.
    Alfouzan W; Dhar R; Ashkanani H; Gupta M; Rachel C; Khan ZU
    J Mycol Med; 2015 Mar; 25(1):23-8. PubMed ID: 25534676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
    Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species.
    Sobel JD; Sobel R
    Expert Opin Pharmacother; 2018 Jun; 19(9):971-977. PubMed ID: 29932786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vulvovaginal candidiasis in a Flemish patient population.
    De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
    Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Candida albicans-closely related yeasts, Candida africana and Candida dubliniensis, in vulvovaginal candidiasis.
    Shan Y; Fan S; Liu X; Li J
    Med Mycol; 2014 Aug; 52(6):636-40. PubMed ID: 25023482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental rat vaginal infection with Candida parapsilosis.
    De Bernardis F; Lorenzini R; Morelli L; Cassone A
    FEMS Microbiol Lett; 1989 Nov; 53(1-2):137-41. PubMed ID: 2612881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
    Fan SR; Liu XP; Li JW
    J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal pH and microbiota during fluconazole maintenance treatment for recurrent vulvovaginal candidosis (RVVC).
    Donders GG; Grinceviciene S; Ruban K; Bellen G
    Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115024. PubMed ID: 32253071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and distribution of vaginal yeasts in Malaysian women.
    Ngeow YF; Soo-Hoo TS
    Mycoses; 1989 Nov; 32(11):563-7. PubMed ID: 2615779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell damage caused by vaginal Candida albicans isolates from women with different symptomatologies.
    Faria DR; Sakita KM; Akimoto-Gunther LS; Kioshima ÉS; Svidzinski TIE; Bonfim-Mendonça PS
    J Med Microbiol; 2017 Aug; 66(8):1225-1228. PubMed ID: 28771140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on the relationship between vaginal and intestinal candida in patients with vulvovaginal candidiasis].
    Lin XL; Li Z; Zuo XL
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):496-500. PubMed ID: 22041440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolving pathogens in vulvovaginal candidiasis: implications for patient care.
    Horowitz BJ; Giaquinta D; Ito S
    J Clin Pharmacol; 1992 Mar; 32(3):248-55. PubMed ID: 1564129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012.
    Liu XP; Fan SR; Peng YT; Zhang HP
    J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent vulvovaginal candidiasis.
    Giraldo P; von Nowaskonski A; Gomes FA; Linhares I; Neves NA; Witkin SS
    Obstet Gynecol; 2000 Mar; 95(3):413-6. PubMed ID: 10711554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species.
    Martins HP; da Silva MC; Paiva LC; Svidzinski TI; Consolaro ME
    Acta Derm Venereol; 2012 Jan; 92(1):78-82. PubMed ID: 21918792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vulvovaginal candidiasis].
    Svobodová L; Lysková P; Hamal P
    Klin Mikrobiol Infekc Lek; 2015 Sep; 21(3):74-81. PubMed ID: 26636630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.